SOX2 and OCT4, along with other induced pluripotent stem cell markers KLF4, NANOG, and c-MYC, regulate stemness in CSCs [55] and have been used them to characterize CSCs in other cancer types [19,20,21,22,23,24,25,26,27,28,29]. This evidence concerns the gene MYC and cancer.